Search by Drug Name or NDC
NDC 13668-0201-01 moxifloxacin hydrochloride 400 mg/1 Details
moxifloxacin hydrochloride 400 mg/1
moxifloxacin hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Torrent Pharmaceuticals Limited. The primary component is MOXIFLOXACIN HYDROCHLORIDE.
MedlinePlus Drug Summary
Moxifloxacin is used to treat certain infections caused by bacteria such as pneumonia, and skin, and abdominal (stomach area) infections. Moxifloxacin is also used to prevent and treat plague (a serious infection that may be spread on purpose as part of a bioterror attack. Moxifloxacin may also be used to treat bronchitis or sinus infections but should not be used for these conditions if there are other treatment options available. Moxifloxacin is in a class of antibiotics called fluoroquinolones. It works by killing the bacteria that cause infections. Antibiotics such as moxifloxacin will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 13668-0201-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Moxifloxacin
Product Information
| NDC | 13668-0201 |
|---|---|
| Product ID | 13668-201_f86e9a64-52b0-24cb-e053-6294a90a2bc7 |
| Associated GPIs | 05000037100320 |
| GCN Sequence Number | 043879 |
| GCN Sequence Number Description | moxifloxacin HCl TABLET 400 MG ORAL |
| HIC3 | W1Q |
| HIC3 Description | QUINOLONE ANTIBIOTICS |
| GCN | 50767 |
| HICL Sequence Number | 020690 |
| HICL Sequence Number Description | MOXIFLOXACIN HCL |
| Brand/Generic | Generic |
| Proprietary Name | moxifloxacin hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | moxifloxacin hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 400 |
| Active Ingredient Units | mg/1 |
| Substance Name | MOXIFLOXACIN HYDROCHLORIDE |
| Labeler Name | Torrent Pharmaceuticals Limited |
| Pharmaceutical Class | Quinolone Antimicrobial [EPC], Quinolones [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA200160 |
| Listing Certified Through | n/a |
Package
NDC 13668-0201-01 (13668020101)
| NDC Package Code | 13668-201-01 |
|---|---|
| Billing NDC | 13668020101 |
| Package | 100 TABLET in 1 BOTTLE (13668-201-01) |
| Marketing Start Date | 2014-04-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |